Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis

Biomarker Research

Table 1 Patient characteristics

	Baseline	Week 4	Week 8	Week 12	Week 16	Week 20	Week 24
Hemoglobin	12	11.7	11.3	10.5	10.9	11.4	11.6
Platelet count	188	246	277	297	314	296	250
WBC	6.3	6.8	6.9	7.3	7.4	8.0	8.3
Creatinine	0.85	0.88	0.89	0.92	1.02	1.16	1.03
ALT/AST	Normal	Normal	Normal	Normal	Normal	Normal	Normal
Amylase/Lipase	Normal	Normal	Normal	Normal	Normal	Normal	Normal
EKG	Normal	Normal	Normal	Normal	Normal	Normal	Normal
Weight (Kg)	77.9	78.4	80.5	83.7	85.2	85.6	84.6
Tryptase	10.2	NA	10.8	9.6	NA	9.5	9.1
Ruxolitinib dose	5 mg BID	10 mg BID	20 mg BID	15 mg BID	10 mg BID	10 mg BID	5 mg BID

ISSN: 2050-7771